Intrasac fibrin glue injection after platinum coils placement: the efficacy of a simple intraoperative procedure in preventing type II endoleak after endovascular aneurysm repair

Pilon, Fabio; Tosato, Federico; Danieli, Dario; Campanile, Francesco; Zaramella, Massimiliano; Milite, Domenico

doi:10.1510/icvts.2009.231167

Cited by 30 publications

(28 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incidence of type II endoleak was significantly lower with TISSEEL (5.5% vs. 30.0%; p = 0.05). The TISSEEL group also underwent significantly fewer abdominal computed tomography studies per year (1.2 vs. 2.0; p = 0.05), although the number of minutes of X‐ray exposure was comparable in the two groups (32.3 vs. 30.0 minutes, respectively) …”

Section: Resultsmentioning

confidence: 97%

“…The thrombization technique was associated with a significantly lower risk of type II endoleak (incidence, 2.2% vs. 15.2%; hazard ratio, 0.13; p < 0.0001) . A small retrospective study involving patients with nonruptured AAA managed using endovascular aneurysm repair compared the incidence of type II endoleak in patients in whom TISSEEL had been injected into the aneurysm sac at the end of the procedure and those in whom it had not (mean follow‐up, 18.5–20.0 months) . The incidence of type II endoleak was significantly lower with TISSEEL (5.5% vs. 30.0%; p = 0.05).…”

Section: Resultsmentioning

confidence: 99%

“…Clinical trials have shown that fibrin sealants have been successful in improving outcomes compared with standard techniques in patients with a wide range of cardiovascular conditions . For example, in coronary artery bypass graft (CABG) surgery, fibrin sealant agents are used as adjunctive hemostatic agents to control bleeding from distal or proximal anastomoses (Fig.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Use of Fibrin Sealants in Cardiovascular Surgery: A Systematic Review

Rousou

2013

J Card Surg

View full text Add to dashboard Cite

Background: Fibrin sealants are used for hemostasis and tissue adherence. Aim of Study: This systematic review summarizes published clinical data for fibrin sealant use in cardiovascular surgery. Methods: A literature search for the following terms was conducted using PubMed and EMBASE: (TISSEEL or Tissucol or Beriplast P or Evicel or Quixil or Crosseal or Reliseal or Fibringluraas or Bolheal or Tachosil or Vivostat or Vitagel or Artiss or ''fibrin glue'' or ''fibrin sealant'' or ''fibrin tissue adhesive'') and (cardiac or cardiovascular or vascular or heart or coronary or surgery). Case reports and series were excluded; although reports of controlled trials were preferred, uncontrolled trial data were also considered. Results: Clinical trials and chart review analyses of fibrin sealants were identified and summarized. Although clinical trial data were available for other agents, the majority of published studies examined TISSEEL. Overall, TISSEEL and other fibrin sealants showed improvements over standard of care or control groups for a variety of predefined endpoints. Safety findings are also summarized. Conclusions: Data from these studies showed that fibrin sealants were well tolerated and provided effective hemostasis in a range of cardiac and aortic surgeries.

show abstract

Section: Resultsmentioning

confidence: 97%

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Use of Fibrin Sealants in Cardiovascular Surgery: A Systematic Review

Rousou

2013

J Card Surg

View full text Add to dashboard Cite

show abstract

“…The literature is replete with multiple suggested routes of T2EL ablation, including laparoscopic ligation of the inferior mesenteric artery, 13 concurrent operative lumbar embolization, 14,15 post-EVAR embolizations, 16,17 and post-EVAR operative approaches. 18 Previously, our institutional experience has shown that continued observation of persistent T2EL with stable aneurysm sac size is both safe and cost-effective.…”

Section: Discussionmentioning

confidence: 99%

Outcomes of percutaneous endovascular intervention for type II endoleak with aneurysm expansion

Aziz

Menias

Sánchez

et al. 2012

Journal of Vascular Surgery

109

View full text Add to dashboard Cite

In this series, percutaneous endovascular intervention for type II endoleak with aneurysm sac growth does not appear to alter the rate of aneurysm sac growth, and the majority of patients display persistent/recurrent endoleak. However, diagnostic angiographic evaluation may reveal unexpected type I and III endoleaks and is therefore recommended for all patients with T2EL and sac growth. While coil and glue embolization of aneurysm sac and selected branch vessels does not appear to yield benefit in our series, the diagnosis and subsequent definitive treatment of previously occult type I and III endoleaks may explain the absence of delayed rupture and ARM in our series.

show abstract

“…The use of microcoils, n-butyl 2-cyanoacrylate adhesive, or other embolic agents (such as Onyx) have been utilized to treat type I endoleaks, but their effectiveness is still unproven [6,9,10]. Studies of fibrin glue embolization of endoleak are few and primarily focused on the prevention of type II endoleak [11][12][13]. So we examined our 5-year experience using fibrin glue to assess the technique's feasibility, safety, and effectiveness in treating type I endoleaks in the intraoperative setting.…”

Section: Fibrin Glue Sac Embolization To Treat Type Ia Endoleakmentioning

confidence: 99%